Quick Facts
  • pin location icon
    Primary Location:
    New York-Presbyterian Hospital/Columbia University Medical Center
  • wavy circle icon with check mark inside
    Expertise:
    Thoracic Cancer
    Immunotherapy
  • magnifying glass with heart icon
    Speciality:
    Hematology
  • gender symbols interlocked icon
    Gender:
    Male
  • chat box with different language translations icon
    Language:
    English
  • certificate with a ribbon icon below
    Med School:
    Rutgers New Jersey Medical School

Get to Know Dr. Brian Henick

Medical oncologist Dr. Brian Henick specializes in thoracic malignancies, including lung cancer and mesothelioma, and in personalizing patient care through novel therapeutics.

Henick believes in a multidisciplinary approach to treatment that includes the computational study of cancer immunobiology, the latest advancement in cancer care.

With every patient he serves, his goal is improving the current treatment strategy by maximizing the vast resources of one of the country’s leading cancer centers and its mesothelioma doctors.

The National Cancer Institute has recognized the Columbia University Herbert Irving Comprehensive Cancer Center as an elite Comprehensive Cancer Center for more than 30 years.

Henick takes pride in staying attuned to the values and needs of each individual. His areas of treatment expertise include esophageal cancer and thymoma through the field of hematology.

He also serves as an associate professor of medicine at the Columbia University Irving Medical Center.

Contact Dr. Brian Henick
medical stethoscope icon
By submitting, you agree to our privacy policy and disclaimer. Our Patient Advocates may contact you via phone, email and/or text.

Specialties of Dr. Brian Henick

  • Immunotherapy
  • Lung cancer
  • Pleural mesothelioma
  • Esophageal cancer
  • Hematology
  • Oncology
  • Thoracic cancers

Dr. Brian Henick’s Experience and Medical Education

  • Columbia University Herbert Irving Comprehensive Cancer Center
  • Rutgers New Jersey Medical School (M.D.)
  • Yale New Haven Hospital (Fellowship, residency, internship)

Awards and Other Recognitions

  • ASCO Journals Editorial Fellowship
  • Conquer Cancer/ASCO Foundation Merit Award
  • Conquer Cancer/ASCO Young Investigator Award
  • Society for Immunotherapy of Cancer Sparkathon
  • Gold Humanism Honor Society

Publications of Dr. Brian Henick

  • Henick, B. (2020, February 11). Elite Intratumoral T-cell Clonotypes (The 1%) Effect “Trickle-Down Cytotoxicity.” Clinical Cancer Research.
  • Zugazagoitia, J. et al. (2019, October 9). Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer. Journal of Thoracic Oncology.
  • Henick, B. et al. (2014, December 18). The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer. Expert Opinion on Thoracic Targets.
people watching webinar on computer
Browse Our Free Mesothelioma Webinars
group of people holding money
Access More than $32 Billion in Trust Funds
scientists in laboratory
Find Active Mesothelioma Clinical Trials